ID   BL-33
AC   CVCL_M557
SY   BL33; BL 33; IARC/BL33; IARC/BL 33; IARC-BL33; IARC BL33; IARC BL 33
DR   DSMZ; ACC-952
DR   Wikidata; Q54797140
RX   PubMed=3027441;
RX   PubMed=3035497;
RX   PubMed=3934070;
RX   PubMed=6090749;
RX   PubMed=6806672;
RX   PubMed=6825067;
RX   PubMed=7519050;
CC   From: International Agency of Research on Cancer (IARC); Lyon; France.
CC   Population: Caucasian.
CC   Virology: EBV-negative.
CC   Doubling time: ~24 hours (DSMZ=ACC-952).
CC   Sequence variation: Gene fusion; HGNC; HGNC:5853; IGL + HGNC; HGNC:7553; MYC; Name(s)=MYC-IGL (PubMed=6806672; PubMed=7519050).
CC   Derived from site: In situ; Bone marrow; UBERON=UBERON_0002371.
CC   Cell type: B-cell; CL=CL_0000236.
ST   Source(s): DSMZ=ACC-952
ST   Amelogenin: X
ST   CSF1PO: 10,11
ST   D13S317: 8,9
ST   D16S539: 12
ST   D18S51: 14
ST   D19S433: 13
ST   D21S11: 29,30
ST   D2S1338: 23,24
ST   D3S1358: 15,16
ST   D5S818: 7,12
ST   D7S820: 9,11
ST   D8S1179: 13,16
ST   FGA: 19,21
ST   Penta D: 14,17
ST   Penta E: 7,10
ST   TH01: 8,9
ST   TPOX: 10
ST   vWA: 16,18
DI   NCIt; C2912; Burkitt lymphoma
DI   ORDO; Orphanet_543; Burkitt lymphoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   35Y
CA   Cancer cell line
DT   Created: 05-11-13; Last updated: 19-12-24; Version: 19
//
RX   PubMed=3027441; DOI=10.1093/jnci/78.2.235;
RA   Cohen J.H.M., Revillard J.-P., Magaud J.-P., Lenoir G.M., Vuillaume M.,
RA   Manel A.-M., Vincent C., Bryon P.-A.;
RT   "B-cell maturation stages of Burkitt's lymphoma cell lines according
RT   to Epstein-Barr virus status and type of chromosome translocation.";
RL   J. Natl. Cancer Inst. 78:235-242(1987).
//
RX   PubMed=3035497; DOI=10.1093/nar/15.11.4553; PMCID=PMC340879;
RA   Szajnert M.-F., Saule S., Bornkamm G.-W., Wajcman H., Lenoir G.M.,
RA   Kaplan J.-C.;
RT   "Clustered somatic mutations in and around first exon of
RT   non-rearranged c-myc in Burkitt lymphoma with t(8;22) translocation.";
RL   Nucleic Acids Res. 15:4553-4565(1987).
//
RX   PubMed=3934070;
RA   Lenoir G.M., Vuillaume M., Bonnardel C.;
RT   "The use of lymphomatous and lymphoblastoid cell lines in the study of
RT   Burkitt's lymphoma.";
RL   IARC Sci. Publ. 60:309-318(1985).
//
RX   PubMed=6090749; DOI=10.1093/jnci/73.4.835;
RA   Philip I., Philip T., Favrot M.-C., Vuillaume M., Fontaniere B.,
RA   Chamard D., Lenoir G.M.;
RT   "Establishment of lymphomatous cell lines from bone marrow samples
RT   from patients with Burkitt's lymphoma.";
RL   J. Natl. Cancer Inst. 73:835-840(1984).
//
RX   PubMed=6806672; DOI=10.1038/298474a0;
RA   Lenoir G.M., Preud'homme J.-L., Bernheim A., Berger R.;
RT   "Correlation between immunoglobulin light chain expression and variant
RT   translocation in Burkitt's lymphoma.";
RL   Nature 298:474-476(1982).
//
RX   PubMed=6825067; DOI=10.1016/0165-4608(83)90138-3;
RA   Bernheim A., Berger R., Lenoir G.M.;
RT   "Cytogenetic studies on Burkitt's lymphoma cell lines.";
RL   Cancer Genet. Cytogenet. 8:223-229(1983).
//
RX   PubMed=7519050; DOI=10.1002/gcc.2870090408;
RA   Zeidler R., Joos S., Delecluse H.-J., Klobeck H.-G., Vuillaume M.,
RA   Lenoir G.M., Bornkamm G.-W., Lipp M.;
RT   "Breakpoints of Burkitt's lymphoma t(8;22) translocations map within a
RT   distance of 300 kb downstream of MYC.";
RL   Genes Chromosomes Cancer 9:282-287(1994).
//